Home › Hereditary Angioedemas › Arizona
Hereditary Angioedemas clinical trials in Arizona
3 studies for Hereditary Angioedemas are looking for participants at sites in Arizona.
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
- ADARx Clinical Site, Litchfield Park
- ADARx Clinical Site, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06960213Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
- ADARx Clinical Site, Litchfield Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07428499A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
- Medical Research of Arizona, Phoenix
RecruitingObservational study
Ages 12 and older · All sexes · Updated Jun 3, 2026 · NCT07001280From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.